K. Lehmann

Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration

B. Lemmer, K. Witte, E. Mutschler, 1993, Clinical pharmacology and therapeutics.

First dose hypotension with enalapril and prazosin in congestive heart failure.

J. Hasford, W. Bussmann, W. Delius, 1991, International journal of cardiology.

On the Problems of Switching from Intravenous to Oral Administration in Drug Treatment of Endogenous Depression

E. Rüther, G. Hajak, G. Hoffmann, 1997, Pharmacopsychiatry.

[Are there predictors for impulsive, homicidal-suicidal acts of violence].

G. Hajak, K. Lehmann, K. Räder, 1994, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects

H. Vetter, R. Düsing, E. Mutschler, 2004, European Journal of Clinical Pharmacology.

Beneficial clinical effect of very early enalapril treatment in patients with acute left ventricular failure complicating myocardial infarction

J. Hasford, W. Delius, J. Nussberger, 1995, Clinical cardiology.

[Molsidomine in ergometric tests (author's transl)].

K. Lehmann, D. Röhl, 2008, Deutsche medizinische Wochenschrift.

CART and logistic regression analyses of risk factors for first dose hypotension by an ACE-inhibitor.

J Hasford, J. Hasford, H Ansari, 1993, Therapie.

Angiotensin-converting enzyme inhibitors may cause renal dysfunction in patients on long-term lithium treatment.

E. Ritz, K. Lehmann, K. Lehmann, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effect of cilazapril on the proliferative response after vascular damage.

J. Powell, K. Lehmann, 1993, Journal of Cardiovascular Pharmacology.